1. 1587PHow do Spanish medical oncologists manage breakthrough pain? A national study. (18th September 2017) Authors: Aranda, E.; Camps Herrero, C.; Khosravi, P.; Feyjoo, M.; Anton Torres, A.; Gascon, P.; Garcia Foncillas, J.; Diaz Rubio, E.; Guillem Porta, V.; Carrato, A.; Constenla Figueiras, M.; Cruz Hernandez, J.J.; López, R. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Awareness and understanding of venous thromboembolism in patients with cancer: data on 100 unselected cancer outpatients. Issue 164 (April 2018) Authors: Nicolau, B.; García-Morillo, M.; Rodriguez, A.; García-Villa, A.; Cortes, K.S.; Calderon, C.; Beato, C.; Palomares, L.J.; Otero, R.; Gascon, P.; Monreal, M.; Font, C. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neuropilin 2 regulates lung disseminated tumor cells escape from dormancy and progression into metastasis. (July 2016) Authors: Bragado, P.; Alonso, R.; Mancino, M.; Fernandez-Nogueira, P.; Fuster, G.; Gascon, P. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-063: Awareness of venous thromboembolism in patients with cancer: does the gender matter?. Issue 151 (March 2017) Authors: Nicolau, B.; García-Morilla, M.; Stefi Cortes, K.; Calderon, C.; Gascon, P.; Suarez, C.; Jara Palomares, L.; Colomé, E.; Manazaneda, J.; Fernandez-Ortega, P.; Otero, R.; Monreal, M.; Font, C. Journal: Thrombosis research Issue: Issue 151(2017)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment patterns and outcomes in patients with breast cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study. (April 2018) Authors: Aapro, M.; Krendyukov, A.; Krivtsova, N.; Gascon, P. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment patterns and outcomes in the DLBCL cohort of a study (MONITOR‐GCSF) assessing biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropenia. (June 2017) Authors: Gascon, P.; Krendyukov, A.; Höbel, N.; Aapro, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗